Biostar Pharmaceuticals looks for encore after huge gain, Q3 report

|About: Biostar Pharmaceutic (BSPM)|By:, SA News Editor

China-based Biostar Pharmaceuticals (BSPM) rises 4% premarket after posting Q3 results Thursday evening.

The company earned $0.03/share on revenue of $15M (+50% Y/Y). (PR)

Of note: BSPM rose 60% during regular trading Thursday.